Tokyo Tape
Sign in
← Nissha

Quarterly report · Q3

7915.TEDINET S100PHZY
Period2022-01-01 → 2022-09-30
Filed2022-11-11
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 52
MetricValuePeriodScopeSource row
Operating income¥9.7bn2022-01-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥3.4bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥15.5bn2021-01-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥4.6bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥13.9bn2022-01-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥4.4bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥19.5bn2021-01-01 → 2021-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥16.9bn2021-01-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥4.7bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥11.8bn2022-01-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥3.9bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥15.9bn2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥14.5bn2021-01-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥3.9bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥11.8bn2022-01-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥3.9bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥14.5bn2021-01-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥3.9bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥239.3bnat 2022-09-30Cons.Assets IFRS
Total assets¥209.3bnat 2021-12-31Cons.Assets IFRS
Total assets¥205.1bnat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥122.7bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥111.0bnat 2021-12-31Cons.Liabilities IFRS
Net assets / equity¥116.6bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥98.3bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥96.3bnat 2021-09-30Cons.Equity IFRS
Net assets / equity¥81.9bnat 2020-12-31dCons.Equity IFRS
Equity (owners)¥116.7bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥98.3bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥96.3bnat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥52.5bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥42.3bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥39.2bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Operating cash flow¥7.9bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥18.8bn2021-01-01 → 2021-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥18.0bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥5.1bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥6.9bn2021-01-01 → 2021-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥4.3bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥2.6bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥2.6bn2021-01-01 → 2021-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥1.9bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥237.142022-01-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥78.522022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥318.352021-01-01 → 2021-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥291.682021-01-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥78.672021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥317.162021-01-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥290.222021-01-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio48.8%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio47.0%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio47.0%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-09-30−¥615m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-07-01 → 2022-09-30−¥169m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-09-30−¥979m
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30−¥579m
jpcrp040300-q3r_E00703-000Devicesreportable segmentsegment profit2022-01-01 → 2022-09-30¥6.6bn
jpcrp040300-q3r_E00703-000Devicesreportable segmentsegment profit2022-07-01 → 2022-09-30¥2.9bn
jpcrp040300-q3r_E00703-000Industrial Materialsreportable segmentsegment profit2022-01-01 → 2022-09-30¥4.5bn
jpcrp040300-q3r_E00703-000Industrial Materialsreportable segmentsegment profit2022-07-01 → 2022-09-30¥1.1bn
jpcrp040300-q3r_E00703-000Medical Technologiesreportable segmentsegment profit2022-01-01 → 2022-09-30¥151m
jpcrp040300-q3r_E00703-000Medical Technologiesreportable segmentsegment profit2022-07-01 → 2022-09-30¥150m
—segment totalsegment profit2022-01-01 → 2022-09-30¥11.3bn
—segment totalsegment profit2022-07-01 → 2022-09-30¥4.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-09-30¥10.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-07-01 → 2022-09-30¥4.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-01-01 → 2021-09-30−¥854m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-07-01 → 2021-09-30−¥316m
Reconciling Itemsreconcilingsegment profit2021-01-01 → 2021-09-30−¥1.1bn
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2021-09-30−¥640m
jpcrp040300-q3r_E00703-000Devicesreportable segmentsegment profit2021-01-01 → 2021-09-30¥12.7bn
jpcrp040300-q3r_E00703-000Devicesreportable segmentsegment profit2021-07-01 → 2021-09-30¥4.1bn
jpcrp040300-q3r_E00703-000Industrial Materialsreportable segmentsegment profit2021-01-01 → 2021-09-30¥4.0bn
jpcrp040300-q3r_E00703-000Industrial Materialsreportable segmentsegment profit2021-07-01 → 2021-09-30¥1.2bn
jpcrp040300-q3r_E00703-000Medical Technologiesreportable segmentsegment profit2021-01-01 → 2021-09-30¥758m
jpcrp040300-q3r_E00703-000Medical Technologiesreportable segmentsegment profit2021-07-01 → 2021-09-30¥271m
—segment totalsegment profit2021-01-01 → 2021-09-30¥17.4bn
—segment totalsegment profit2021-07-01 → 2021-09-30¥5.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-01-01 → 2021-09-30¥16.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-07-01 → 2021-09-30¥5.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 905
ItemContextValueUnit
Profit loss before tax IFRSPrior1QuarterDuration_jpcrp040300-q3r_E00703-000MedicalTechnologiesReportableSegmentMember－JPY
Profit loss before tax IFRSPrior1QuarterDuration_ReportableSegmentsMember－JPY
Profit loss before tax IFRSPrior1QuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Profit loss before tax IFRSPrior1QuarterDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Profit loss before tax IFRSPrior1QuarterDuration_ReconcilingItemsMember－JPY
Profit loss before tax IFRSPrior1QuarterDuration4679000000JPY
Sales to external customers IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000IndustrialMaterialsReportableSegmentMember18777000000JPY
Sales to external customers IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000DevicesReportableSegmentMember23644000000JPY
Sales to external customers IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000MedicalTechnologiesReportableSegmentMember8870000000JPY
Sales to external customers IFRSCurrentQuarterDuration_ReportableSegmentsMember51292000000JPY
Sales to external customers IFRSCurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1872000000JPY
Sales to external customers IFRSCurrentQuarterDuration_TotalOfReportableSegmentsAndOthersMember53165000000JPY
Sales to external customers IFRSCurrentQuarterDuration_ReconcilingItemsMember－JPY
Sales to external customers IFRSCurrentQuarterDuration53165000000JPY
Intersegment sales IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000IndustrialMaterialsReportableSegmentMember36000000JPY
Intersegment sales IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000DevicesReportableSegmentMember2000000JPY
Intersegment sales IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000MedicalTechnologiesReportableSegmentMember0JPY
Intersegment sales IFRSCurrentQuarterDuration_ReportableSegmentsMember39000000JPY
Intersegment sales IFRSCurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember246000000JPY
Intersegment sales IFRSCurrentQuarterDuration_TotalOfReportableSegmentsAndOthersMember285000000JPY
Intersegment sales IFRSCurrentQuarterDuration_ReconcilingItemsMember-285000000JPY
Intersegment sales IFRSCurrentQuarterDuration－JPY
Net sales IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000IndustrialMaterialsReportableSegmentMember18813000000JPY
Net sales IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000DevicesReportableSegmentMember23647000000JPY
Net sales IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000MedicalTechnologiesReportableSegmentMember8871000000JPY
Net sales IFRSCurrentQuarterDuration_ReportableSegmentsMember51331000000JPY
Net sales IFRSCurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember2119000000JPY
Net sales IFRSCurrentQuarterDuration_TotalOfReportableSegmentsAndOthersMember53450000000JPY
Net sales IFRSCurrentQuarterDuration_ReconcilingItemsMember-285000000JPY
Net sales IFRSCurrentQuarterDuration53165000000JPY
Operating profit loss IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000IndustrialMaterialsReportableSegmentMember1136000000JPY
Operating profit loss IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000DevicesReportableSegmentMember2874000000JPY
Operating profit loss IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000MedicalTechnologiesReportableSegmentMember150000000JPY
Operating profit loss IFRSCurrentQuarterDuration_ReportableSegmentsMember4161000000JPY
Operating profit loss IFRSCurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-169000000JPY
Operating profit loss IFRSCurrentQuarterDuration_TotalOfReportableSegmentsAndOthersMember3991000000JPY
Operating profit loss IFRSCurrentQuarterDuration_ReconcilingItemsMember-579000000JPY
Operating profit loss IFRSCurrentQuarterDuration3412000000JPY
Finance income IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000IndustrialMaterialsReportableSegmentMember－JPY
Finance income IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000DevicesReportableSegmentMember－JPY
Finance income IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000MedicalTechnologiesReportableSegmentMember－JPY
Finance income IFRSCurrentQuarterDuration_ReportableSegmentsMember－JPY
Finance income IFRSCurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Finance income IFRSCurrentQuarterDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Finance income IFRSCurrentQuarterDuration_ReconcilingItemsMember－JPY
Finance income IFRSCurrentQuarterDuration1255000000JPY
Finance costs IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000IndustrialMaterialsReportableSegmentMember－JPY
Finance costs IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000DevicesReportableSegmentMember－JPY
Finance costs IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000MedicalTechnologiesReportableSegmentMember－JPY
Finance costs IFRSCurrentQuarterDuration_ReportableSegmentsMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass